Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Join LinkedIn Group
Share This Page
Email
Facebook
Twitter
September 23, 2021
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Cytiva
Click here to read more >>
The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Related Content
mRNA Therapeutics and Vaccines – Key Process Considerations
Genetic Vaccine Platforms Demonstrate Their Potential
Novavax Reports on Two Vaccine Efficacy Studies
Can Vaccine Development Be Safely Accelerated?
mRNA Processing Workflow for Vaccines and Therapeutics
See All Articles…
Click here to read more >>